EU To Reveal Antitrust Cases Against Drugmakers

By Tina Peng

Law360, New York (July 07, 2009, 12:00 AM ET) -- The European Commission is reportedly set to release a report Wednesday regarding its probe into pharmaceutical companies over alleged anti-competitive practices that lead to delays in generic drugs' entry into the market.

The antitrust regulator will release a 600-page report that will say it is pursuing a number of individual cases, but will not name any of the targets, Reuters reported.

The EC launched its inquiry into competition in the pharmaceutical industry in January 2008 with unannounced dawn raids on the European offices of at least...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles